Generex signs LOI to acquire 51% of Hema Diagnostic Systems; Generex acquires remaining stake in HDS
Executive Summary
Generex Biotechnology Corp. signed a letter of intent to purchase a 51% equity stake in infectious disease-focused Hema Diagnostic Systems LLC (HDS) for $15mm.
Deal Industry
- In Vitro Diagnostics
-
Medical Devices
- Diagnostic Equipment & Supplies
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Acquisition
- Includes Contract
- Partial Acquisition
- Payment Includes Cash
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice